Nimbus Therapeutics Series D

Nimbus Therapeutics is a clinical-stage biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery engine. They focus on precision small molecule design for targets implicated in multiple human diseases, including oncology, immunology, and metabolic disorders. Their approach combines cutting-edge computational chemistry, structural biology, and machine learning to accelerate the drug discovery and development process.